For each citation that was shared on social media (LinkedIn, Facebook, or Twitter) with the “@GenScript” tag, the author will be rewarded with a $10 Amazon gift card or 2,000 GS points.

ZEB2 is a master switch controlling the tumor-associated macrophage program

Cancer Cell. 2025-07; 
Fadi Sheban, Truong San Phan, Ken Xie, Florian Ingelfinger, Chamutal Gur, Yuval Shapir Itai, Ronnie Blecher-Gonen, Chunsong Yu, Roberto Avellino, Paulina Chalan, Kiara Freitag, Ido Yofe, Vladimir Yutkin, Pierre Boyeau, Can Ergen, Justin Hong, Kfir Mazuz, Yuxiao Liu, Kangming Chen, Rony Dahan, Marcin Kortylewski, Nir Yosef, Assaf Weiner, Ido Amit
Products/Services Used Details Operation
Synthetic Guide RNA mice intravenously received every 2 days 1 mg/kg of either LNPs (GenScript) carrying Zeb2-targeting guide (LNP-Zeb2) or control LNPs with non-targeting control guide (LNP-NT) in a volume of 100 ml PBS. Get A Quote

Abstract

Tumor-associated macrophages (TAMs) are key mediators of tumor immune evasion. However, their regulatory circuits and checkpoints are partially understood. Here, we generated a TAM regulatory network by integrating human tumors single-cell RNA sequencing (scRNA-seq) data with a dedicated CRISPR screen. Using a deep generative model, we constructed a gene perturbation network linking individual candidates with prototypical TAM functions. We identified Zeb2 as the master regulator of TAM programs, orchestrating suppression of type-I interferon response and antigen presentation alongside activation of immune suppression programs. Genetic ablation of ZEB2 reprograms TAM function and identity on the chromatin, RNA, ... More

Keywords

CRISPR; TAM reprogramming; Zeb2; cancer immunology; cancer immunotherapy; deep generative modeling; regulatory network; single cell genomics; systems immunolgy; tumor-associated macrophage.